As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) today. The company’s shares closed ...

Recent health industry updates reveal Sun Pharma's profit surge due to specialty drugs, Pfizer's strategic focus under ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

Investing.com -- Novartis AG (SIX: NOVN) has raised its annual earnings guidance for the third time, with the drugmaker noting "momentum" in its business and pipeline of medications after it reported ...

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the ...

The third-quarter earnings season was at its peak this week for large drugmakers, with several companies — Eli Lilly LLY, ...

Atrasentan previously demonstrated efficacy in the open-label AFFINITY basket trial, where it reduced the 24-hour urinary ...

Pfizer, Sanofi and others report Q3 beats; AbbVie, Roche and Novartis strike big deals; the 2024 presidential election looms; ...